Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. As one of the world’s largest independent biotechnology companies, Amgen has approximately 24,000 staff in total as of 2022. The name “AMGen” is a portmanteau of the company’s original name, Applied Molecular Genetics, which became the official name of the company in 1983.
The company is listed on the Nasdaq Global Select Market under the ticker symbol “AMGN”, as well as a component of the Nasdaq-100, the Dow Jones Industrial Average, and the S&P 100 and 500 indices.
CEO
Robert A. Bradway
FOUNDED
8 April 1980
HEADQUARTERS
Thousand Oaks, California United States
WEBSITE
amgen.com
NUMBER OF EMPLOYEES
28,000
SECTOR
Healthcare
INDUSTRY
Drug Manufacturers – General
Index
DJIA, NDX, S&P 500
Market Cap
154.96B
Income
5.93B
Sales
33.93B
Book/sh
11.54
Cash/sh
16.38
Dividend Est.
9.63 (3.34%)
Dividend TTM
9.26 (3.21%)
Dividend Ex-Date
May 16, 2025
Employees
28000
Option/Short
Yes / Yes
Sales Surprise
1.14%
SMA20
4.94%
P/E
26.31
Forward P/E
13.39
PEG
6.06
P/S
4.57
P/B
24.96
P/C
17.59
P/FCF
14.2
Quick Ratio
0.88
Current Ratio
1.17
Debt/Eq
9.24
LT Debt/Eq
8.7
EPS Surprise
14.76%
SMA50
0.72%
EPS (ttm)
10.95
EPS next Y
21.52
EPS next Q
5.23
EPS this Y
5.11%
EPS next Y
3.20%
EPS next 5Y
4.34%
EPS past 5Y
-10.10%
Sales past 5Y
7.57%
EPS Y/Y TTM
56.99%
Sales Y/Y TTM
15.59%
EPS Q/Q
1616.98%
Sales Q/Q
9.42%
SMA200
-3.43%
Insider Own
0.22%
Insider Trans
-6.41%
Inst Own
81.05%
Inst Trans
2.37%
ROA
6.51%
ROE
105.67%
ROI
9.85%
Gross Margin
67.43%
Oper. Margin
26.26%
Profit Margin
17.49%
Payout
119.05%
Earnings
May 01 AMC
Trades
48,994
Shs Outstand
537.70M
Shs Float
536.52M
Short Float
2.68%
Short Ratio
4.64
Short Interest
14.36M
52W Range
253.30 – 346.85
52W High
-16.92%
52W Low
13.77%
RSI (14)
58.4
Recom
2.36
Rel Volume
1.76
Avg Volume
3.10M
Volume
5,439,225
Perf Week
5.99%
Perf Month
-0.94%
Perf Quarter
-6.45%
Perf Half Y
-1.98%
Perf Year
-4.00%
Perf YTD
10.57%
Beta
0.49
ATR (14)
7.06
Volatility
1.34% 2.01%
Target Price
311.38
Prev Close
283.54
Price
288.18
Change
1.64%
Information edited and updated on 30/05/2025
KEY FINANCIALS
Institutional Ownership
VANGUARD GROUP INC
9.84%
BlackRock, Inc.
8.46%
STATE STREET CORP
5.43%
Capital World Investors
3.11%
MORGAN STANLEY
3.02%
Capital International Investors
2.82%
GEODE CAPITAL MANAGEMENT, LLC
2.37%
PRIMECAP MANAGEMENT CO/CA/
2.31%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
2.27%
WELLS FARGO & COMPANY/MN
1.35%
Insider Trading
Insider Trading Volume
Income Statement
Period
TTM
FY 2024
FY 2023
Period End Date
—
12/31/2024
12/31/2023
Period Length
12 Months
12 Months
12 Months
Total Revenue
33,929.00
33,232.00
28,010.00
Cost of Goods Sold Incl. D&A
11,050.00
11,899.00
7,709.00
Gross Profit
22,879.00
21,333.00
20,301.00
Selling, General and Administrative Excl. Other
12,997.00
12,772.00
10,434.00
Research and Development
6,081.00
5,676.00
4,755.00
Other Operating Expense
973.00
248.00
690.00
Operating Income
8,909.00
8,313.00
9,177.00
Interest Expense
3,103.00
3,224.00
2,962.00
Unusual Expense
1,597.00
653.00
-290.00
Net Income Before Taxes
6,650.00
4,609.00
7,855.00
Income Taxes
717.00
519.00
1,138.00
Consolidated Net Income
5,933.00
4,090.00
6,717.00
Net Income From Continuing Operations
5,933.00
4,090.00
6,717.00
Net Income
5,933.00
4,090.00
6,717.00
EPS (Recurring)
13.03
8.4
12.11
EPS (Basic, Before Extraordinaries)
11.04
7.62
12.56
EPS (Diluted)
10.95
7.56
12.49
EBITDA
14,489.00
13,905.00
13,062.00
Non-Operating Income (Expense)
2,294.00
173.00
1,350.00
Other After Tax Adjustments
0.00
0.00
0.00
Stock Option Compensation Expense
436.38
416.00
371.00
Price To Earnings Ratio
26.31
26.31
33.20
Price To Sales Ratio
4.97
4.24
5.53
Gross Margin
67.43
64.19
72.48
Operating Margin
26.26
25.02
32.76
Net Margin
17.49
12.31
23.98
Shares Outstanding
537.70
536.90
535.40
Market Capitalization
154,956.12
154,956.12
139,382.31
values in Millions, USD
Balance Sheet
Period
FY 2024
FY 2023
Period End Date
12/31/2024
12/31/2023
Cash & Short Term Investments
11,973.00
10,944.00
Short Term Receivables
7,501.00
7,942.00
Inventories
6,998.00
9,518.00
Other Current Assets
2,558.00
1,928.00
Total Current Assets
29,030.00
30,332.00
Net Property, Plant & Equipment
7,100.00
6,592.00
Total Investments and Advances
5,355.00
4,711.00
Long-Term Note Receivable
—
—
Intangible Assets
46,336.00
51,270.00
Deferred Tax Assets
—
—
Other Assets
4,018.00
4,249.00
Total Assets
91,839.00
97,154.00
Short Term Debt Incl. Current Port. of LT Debt
3,657.00
1,562.00
Accounts Payable
1,908.00
1,590.00
Income Tax Payable
2,583.00
1,664.00
Other Current Liabilities
14,951.00
13,576.00
Total Current Liabilities
23,099.00
18,392.00
Long Term Debt
57,222.00
63,861.00
Provision for Risks Charges
2,349.00
4,680.00
Deferred Tax Liabilities
1,616.00
2,354.00
Other Liabilities
1,676.00
1,635.00
Total Liabilities
85,962.00
90,922.00
Non-Equity Reserves
0.00
0.00
Preferred Stock – Carrying Value
0.00
0.00
Common Equity
5,877.00
6,232.00
Total Shareholders Equity
5,877.00
6,232.00
Accumulated Minority Interest
0.00
0.00
Total Equity
5,877.00
6,232.00
Total Liabilities & Stockholders Equity
91,839.00
97,154.00
Book Value Per Share
10.95
11.64
Tangible Book Value Per Share
-75.36
-84.12
Full-Time Employees
28,000
26,700
Price to Book Ratio
24.96
18.52
Return on Assets
4.33
8.28
Return on Equity
67.55
135.79
Return on Invested Capital
6.48
9.58
Quick Ratio
0.95
1.13
Current Ratio
1.26
1.65
values in Millions, USD
Cash Flow
Period
TTM
FY 2024
FY 2023
Period End Date
—
12/31/2024
12/31/2023
Period Length
12 Months
12 Months
12 Months
Funds from Operations
16,513.00
15,940.00
14,733.00
Extraordinary Item
0.00
0.00
0.00
Changes in Working Capital
-3,251.00
-1,890.00
3,821.00
Income Taxes Payable
—
—
—
Cash from Operating Activities
13,262.00
14,050.00
18,554.00
Capital Expenditures
-1,950.00
-1,917.00
-1,565.00
Net Assets From Acquisitions
-454.00
-454.00
-64.00
Sale of Fixed Assets and Businesses
599.00
600.00
2.00
Purchase or Sale of Investments
797.00
628.00
2,318.00
Purchase of Investments
-1,425.00
-1,593.00
-1,572.00
Sale Or Maturity of Investments
2,222.00
2,221.00
3,890.00
Other Uses
0.00
0.00
0.00
Other Sources
0.00
0.00
0.00
Cash from Investing Activities
-20,807.00
-24,402.00
-24,433.00
Cash Dividends Paid
-2,056.00
-1,999.00
-1,780.00
Change in Capital Stock
-5,843.00
-5,920.00
-3,622.00
Repurchase of Common Pref Stock
-5,936.00
-6,020.00
-3,650.00
Sale of Common Pref Stock
93.00
100.00
28.00
Proceedsfrom Stock Options
93.00
100.00
28.00
Issuance or Reduction of Debt, Net
1,802.00
2,050.00
4,866.00
Change in Long Term Debt
1,982.00
1,843.00
4,971.00
Issuance of Long Term Debt
15,025.00
12,602.00
15,674.00
Reduction of Long Term Debt
-13,043.00
-10,759.00
-10,703.00
Net Financing Active Other Cash Flow
0.00
0.00
0.00
Other Financing Activities Uses
0.00
0.00
0.00
Cash from Financing Activities
5,898.00
4,436.00
18,384.00
Exchange Rate Effect
-58.00
-40.00
177.00
Net Change in Cash
-1,705.00
-5,956.00
12,682.00
Free Cash Flow
11,312.00
12,133.00
16,989.00
Preferred Dividends (Cash Flow)
—
—
—
Price to Free Cash Flow
20.41
20.88
9.07
values in Millions, USD
Amgen Inc at a Glance
Amgen Inc Financials at a glance including: EPS, Sales, Shares Outstanding, SPY Comparison, Short Interest, Short Interest History, EPS Performance and Forecast, GAAP EPS Performance and Forecast, Revenue Performance and Forecast, Price Reactions to Earnings Reports, Latest Revisions, Revenue by Products and Services, Revenue by Regions, Revenue by Segment, Dividends, and Dividend Payout History.
Please Note: Information edited and updated on 30/05/2025
Index – Major index membership
Market Cap – Market capitalization
Income – Trailing 12 months income
Sales – Trailing 12 months revenue
Book/sh – Most recent quarter book value a share
Cash/sh – Most recent quarter cash per share
Dividend Est. – Analysts’ dividend estimate (fiscal year)
Dividend TTM – Trailing 12-month dividend
Dividend Ex-Date – Ex-dividend date
Employees – Number of full-time employees
Option/Short – Stock has options on a market exchange/stock is available to sell short
Sales Surprise – Last quarter revenue surprise
SMA20 – Stock price distance from 20-day simple moving average
P/E – Price-to-Earnings (trailing 12-months)
Forward P/E – Forward Price-to-Earnings (next fiscal year)
PEG – Price-to-Earnings-to-Growth
P/S – Price-to-Book (most recent quarter)
P/B – Price-to-Book (most recent quarter)
P/C – Price to cash per share (most recent quarter)
P/FCF – Price to Free Cash Flow (trailing 3-months)
Quick Ratio – Quick Ratio (most recent quarter)
Current Ratio – Current Ratio (most recent quarter)
Debt/Eq – Total Debt to Equity (most recent quarter)
LT Debt/Eq – Long Term Debt to Equity (most recent quarter)
EPS Surprise – Last quarter Earnings-Per-Share surprise
SMA50 – Stock price distance from 50-Day Simple Moving Average
EPS (ttm) – Diluted Earnings-Per-Share (trailing 3-months)
EPS next Y – Earnings-Per-Share estimate for next year
EPS next Q – Earnings-Per-Share estimate next quarter
EPS this Y - Earnings-Per-Share growth this year
EPS next Y - Earnings-Per-Share estimate for next year
EPS next 5Y – Long term annual growth estimate (5 years)
EPS past 5Y – Annual Earnings-Per-Share growth past 5 years
Sales past 5Y – Annual sales growth past 5 years
EPS Y/Y TTM – Earnings-Per-Share growth (trailing 3 months)
Sales Y/Y TTM – Sales growth (trailing 3 months)
EPS Q/Q – Quarterly earnings growth (Year-on-Year)
Sales Q/Q – Quarterly revenue growth (Year-on-Year)
SMA200 – Stock price distance from 2-Day Simple Moving Average
Insider Own – Percentage insider ownership of company shares
Insider Trans – Insider transactions (6-month change in Insider Ownership)
Inst Own – Institutional ownership
Inst Trans - Institutional transactions (3-month change in Institutional Ownership)
ROA – Return on Assets (trailing 3-months)
ROE – Return on Equity (trailing 3-months)
ROI – Return on Investment (trailing 3-months)
Gross Margin – Gross Margin (trailing 3-months)
Oper. Margin – Operating Margin (trailing 3-months)
Profit Margin – Net Profit Margin (trailing 3-months)
Payout – Dividend Payout Ratio (trailing 3-months)
Earnings – BMO = Before Market Open / AMC = After Market Close
Shs Outstand – Shares outstanding
Shs Float – Shares float
Short Float – Short interest share
Short Ratio – Short interest ratio
Short Interest – Short interest
52W Range – 52-Week trading range
52W High – Distance from 52-Week High
52W Low - Distance from 52-Week Low
RSI (14) – Relative Strength Index
Perf Week – Performance (Week)
Perf Month – Performance (Month)
Perf Quarter – Performance (Quarter)
Perf Half Y - Performance (Half Year)
Perf Year – (Year)
Perf YTD - Performance (Year-To-Date)
Beta - Beta
ATR (14) – Average True Range
Volatility – Volatility (Week, Month)
Target Price – Analysts’ mean target price
Price – Current stock price
